Tomasi PA, Fanciulli G, Palermo M, Pala A, Demontis MA, Delitala G. Opioid-receptor blockade blunts growth hormone (GH) secretion induced by GH-releasing hormone in the human male.
Horm Metab Res 1998;
30:34-6. [PMID:
9503036 DOI:
10.1055/s-2007-978827]
[Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
OBJECTIVE
To investigate the existence of an opioid stimulatory tone on growth hormone (GH) secretion in the human male.
DESIGN
Seven healthy male volunteers, aged 19-30, were studied in the Endocrine Unit of the University of Sassari. GH-releasing hormone (GHRH), 100 micrograms as an intravenous (IV) bolus, as administered with and without preadministration of IV naloxone, 2 mg as a bolus followed by a constant infusion of 2 mg/h. Blood samples were taken for 120 minutes after GHRH administration.
RESULTS
Naloxone significantly blunted the GH response to GHRH, measured either as mean peak value (at times 30 to 90) or as integrated concentrations.
CONCLUSIONS
Naloxone is able to decrease the effect of a maximal dose of GHRH, thus suggesting the existence of an opioid stimulatory tone on GH secretion.
Collapse